US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Radiopharm Theranostics Ltd (RADO) 銘柄情報

Radiopharm Theranostics Ltd (RADO)

0.001

0.00

(0.00%)

終了 6月13日 3:00PM

Radiopharm Theranostics Ltd (RADO) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.001 52 週間の範囲 0.004

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,602,972

発行済株式数

3,544,216,160

配当利回り

PER

-1

1 株当たり利益 (EPS)

-0.02

歳入

16.28M

純利益

-46.58M

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.radiopharmtheranostics.com

本社

Carlton, Australia

設立

2026

Radiopharm Theranostics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker RADO. The last closing price for Radiopharm Theranostics was AUD0. Over the last year, Radiopharm Theranostics shares have traded in a share price range of AUD 0.001 to AUD 0.004.

Radiopharm Theranostics currently has 3,544,216,160 shares in issue. The market capitalisation of Radiopharm Theranostics is AUD3.54 million. Radiopharm Theranostics has a price to earnings ratio (PE ratio) of -1.00.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0.001	0.003	0.001	834017	0.00187699	DE
52	0	0	0.001	0.004	0.001	720838	0.0016035	DE
156	-0.034	-97.1428571429	0.035	0.043	0.001	323988	0.01270693	DE
260	-0.039	-97.5	0.04	0.07	0.001	289731	0.02219783	DE

RADO - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Ltd share price?

The current share price of Radiopharm Theranostics Ltd is AUD 0.001

How many Radiopharm Theranostics Ltd shares are in issue?

Radiopharm Theranostics Ltd has 3,544,216,160 shares in issue

What is the market cap of Radiopharm Theranostics Ltd?

The market capitalisation of Radiopharm Theranostics Ltd is AUD 3.54M

What is the 1 year trading range for Radiopharm Theranostics Ltd share price?

Radiopharm Theranostics Ltd has traded in the range of AUD 0.001 to AUD 0.004 during the past year

What is the PE ratio of Radiopharm Theranostics Ltd?

The price to earnings ratio of Radiopharm Theranostics Ltd is -1

What is the cash to sales ratio of Radiopharm Theranostics Ltd?

The cash to sales ratio of Radiopharm Theranostics Ltd is 4.14

What is the registered address of Radiopharm Theranostics Ltd?

The registered address for Radiopharm Theranostics Ltd is 62 Lygon Street, Carlton, Victoria, 3053

What is the Radiopharm Theranostics Ltd website address?

The website address for Radiopharm Theranostics Ltd is www.radiopharmtheranostics.com

Which industry sector does Radiopharm Theranostics Ltd operate in?

Radiopharm Theranostics Ltd operates in the Biotechnology & Life Sciences sector

ErnieBilco

ErnieBilco 3分前

It was a SPAC so I'm guessing it just hasn't been VRAXW very long IMO

Best time to get in is before it becomes widely known.

81vette

81vette 3分前

Burst basket trades (institutional buying) started ,that’s why it’s moving up
https://investorshub.advfn.com/stock-market/AMEX/srx-health-solutions-SRXH/trades

Trooperstocks

Trooperstocks 4分前

$GOAI “The partnership with EVA Live through equity compensation reflects our strong belief in GOAI and its long-term potential,” said Chris Fox, CEO of Spiro. “We are choosing to participate in EVA Live as shareholders because we see significant upside in the company’s vision and want to be aligned

Trooperstocks

Trooperstocks 4分前

$GOAI “The partnership with EVA Live through equity compensation reflects our strong belief in GOAI and its long-term potential,” said Chris Fox, CEO of Spiro. “We are choosing to participate in EVA Live as shareholders because we see significant upside in the company’s vision and want to be aligned

abazaba375

abazaba375 4分前

Light volume dip added

doinit

PTHRF,, we need news, coming soon,,,

justus1

justus1 4分前

Would we be allowed to bother your twice a day? lol

Acme Investments

Acme Investments 5分前

👇 I think you have a good point but the lack of consistency on the filings leads me to question profitability!!

BahamaPete

BahamaPete 5分前

I bought 200,000 shares today and that strange trading they were shorting to me below the ask, all my buys were at the ask.

Most likely they will push it lower next week so they can buy back lower for a profit, all crooks if you ask me.

I will have my powder ready for n

sjoseph

sjoseph 5分前

George is no longer with us.🥲 https://www.facebook.com/share/199hE8B5e4/?mibextid=wwXIfr

snupoled

snupoled 6分前

52 week lows briefly today! But
Congratulations retail, we were trading at these
Same levels a decade ago
What made u buy today?
Make it a great weekend
Snup

Doc logic

Doc logic 6分前

brazen22,

The greatest trial design limitation was figuring out a way to measure treatment effect with crossover to an active treatment being part of the trial design due to all patients being put through an invasive procedure with leukapheresis and FDA saying patients should have a r

doinit

more large corporate interest in Alaska
https://alaskabeacon.com/2026/06/11/meet-the-spanish-company-at-the-heart-of-alaskas-oil-industry-revival/

Trooperstocks

Trooperstocks 6分前

$TDTH Building upon the Company’s previously disclosed Ghana Revenue Authority deployment targeting more than 530,000 Micro, Small and Medium Enterprises (“MSMEs”) and supporting projected platform economics of approximately US$800 million over an initial five-year operating horizon, TDTHAI Africa i

Trooperstocks

Trooperstocks 6分前

$TDTH Building upon the Company’s previously disclosed Ghana Revenue Authority deployment targeting more than 530,000 Micro, Small and Medium Enterprises (“MSMEs”) and supporting projected platform economics of approximately US$800 million over an initial five-year operating horizon, TDTHAI Africa i

sjoseph

sjoseph 7分前

George’s brother Sid posted it on facebook. He is no more.🥲https://www.facebook.com/share/199hE8B5e4/?mibextid=wwXIfr

csuck555

csuck555 7分前

Last chance to sell 200k to me for .33 before I take it down to .29 next week.
Ahhahahahah. These are shares i sold at .43. Thanks pumpers for helping me mint more bagholders.

doinit

PTHRF,, picture of petroleum reserve in Alaska
https://www.blm.gov/sites/blm.gov/files/uploads/EnergyMinerals_OilandGas_Alaska_NPR-A_Map.jpg

timberwolf7

timberwolf7 7分前

Too bad their aren't PUT options on SPCX when it was over $160...

Priced to perfection and then some is not a winning recipe for investors.
Can't imagine how many have had to 'get some' purely because of the hype.

And now with RKLB sliding back towards a more 're

81vette

81vette 7分前

Bought more, 87,000 shares

TightCoil

TightCoil 7分前

FNMA/FMCC
SET TO EXPLODE within the next 10 minutes.
Pack a few in NOW!

CommodityCoverage

CommodityCoverage 7分前

Posted on behalf of Carrier Connect Data Solutions Inc. - Carrier Connect (CCDS.v CCDSF) is making its first move into the U.S. data center market with the acquisition of Rochester Colo: https://x.com/StckMasterFlash/status/2064772836812603855

This transaction is expected to immediat

lakers17

lakers17 8分前

Took a re-entry back into SOAR way lower this time at .0182. Had sold at a small profit after averaging down many times.

Trooperstocks

Trooperstocks 8分前

$NCRA Nocera's announcement marked an important milestone in Nocera’s evolution.

By combining the IRMA AI Engine, strategic acquisition sourcing, capital markets expertise, and our previously announced $300M growth facility, we’re creating a platform designed to identify, fund, suppor

BlazingStocks

BlazingStocks 8分前

🔥 $BURU
? NUBURU's core advantage has always been blue-laser innovation
? Lyocon is expected to transform that expertise into manufacturable industrial solutions
? Engineering capability plus production capacity can be a powerful growth engine
? The SunCubes colla

Radiopharm Theranostics

Tradeweb Markets

Gaztransport and Tecnigaz (PK)

Columbia Real Estate Equ...

Tavia Acquisition

iShares 1-3 Year Credit ...

Torrens Series 2015 1

King River Resources

Gorilla Technology

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。